George Triadafilopoulos
Publication Details
-
Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro-oesophageal reflux disease.
Aliment Pharmacol Ther. 2000; (4): 397-406
Omeprazole was replaced by lansoprazole as the only proton pump inhibitor on the Veterans Affairs (VA) formulary in February 1997. We aimed to assess the clinical and fiscal impact of this conversion at two VA hospitals.

